September 4, 2026

Zinc and Diabetes: New Study Shows Why Single Nutrient Approach Is Not Enough

A new systematic review and meta-analysis of randomized controlled trials has found that zinc supplementation can improve insulin resistance and reduce inflammation and oxidative stress in people with diabetes and related conditions. Notably, however, zinc did not significantly improve every measure of blood sugar control. Rather than this diminishing the importance of nutrition, the findings instead highlight a fundamental problem with the way nutritional therapies are often investigated: complex chronic diseases such as diabetes are unlikely to be optimally controlled by any single nutrient acting alone.
August 28, 2026

Statins and Memory Loss: Mainstream Media Ignores Study Linking America’s Most-Prescribed Drug to Amnesia

A new study examining 20 years of reports submitted to the U.S. Food and Drug Administration (FDA) has found an association between amnesia and four widely used cholesterol-lowering statin drugs, including atorvastatin, the most commonly prescribed drug in America. The finding comes 14 years after the FDA first acknowledged reports of memory loss, forgetfulness, confusion, and amnesia among statin users. Yet despite millions of people taking these drugs every day, the new research has essentially been ignored by the mainstream media.
August 21, 2026

Bribery, Kickbacks, and Fake Research: Study Exposes the Dark Side of Pharma

A remarkable study published earlier this year shed further light on a side of the pharma industry that continues to receive remarkably little attention from the mainstream/legacy media: the deliberate use of bribery and other corrupt practices to increase drug sales, influence prescribing, and secure favorable treatment from governments and regulators. Published online by Cambridge University Press in February 2026, the study examined pharmaceutical bribery cases documented in reports from the Organization for Economic Co-operation and Development (OECD) covering a period of more than 25 years.
August 7, 2026

Vitamin D Can Save Lives in Intensive Care – So Why Don’t Doctors Take Nutrition More Seriously?

A new systematic review and meta-analysis published in the Frontiers in Nutrition journal provides important evidence that vitamin D supplementation can reduce the risk of death among critically ill adults. Analyzing 21 randomized controlled trials, the review found that supplementation significantly reduced overall mortality, with the strongest benefits seen in patients who were vitamin D deficient, those receiving doses of up to 300,000 IU, and those given vitamin D by injection. The findings provide further evidence that doctors need to begin taking nutritional support as seriously as they do drugs, surgery, and other standard medical treatments.
July 24, 2026

The Cancer Prevention Revolution Is Already Here – Mainstream Medicine Just Won’t Admit It

For decades, conventional medicine has largely dismissed vitamin C as little more than the micronutrient that prevents scurvy. In a highly significant development, however, an important new study has concluded that this humble molecule may also have the ability to stop the development of cancer. Published in the Journal of Theoretical Biology, the paper describes how vitamin C can block the formation of potentially cancer-causing chemicals during digestion. For supporters of Cellular Medicine, of course, such findings are less a surprise than a further powerful confirmation that Dr. Matthias Rath was right all along.
May 22, 2026

Ebola Returns: Twelve Years After Dr. Rath’s Warning, Has the World Learned Nothing?

A new Ebola outbreak in the Democratic Republic of Congo (DR Congo) is once again raising fears of a deadly health crisis in Africa. The World Health Organization (WHO) says there are now around 600 suspected cases and 139 suspected deaths, with numbers expected to rise further as investigations continue. Officials warn that the outbreak may have been spreading unnoticed for months before being detected. Yet despite more than a decade having passed since Dr. Matthias Rath argued that micronutrients deserved urgent attention in fighting Ebola, remarkably little work has been done in researching their potential role. While experimental vaccines and drug treatments continue to dominate the response, published scientific studies examining vitamins against Ebola remain virtually nonexistent.
May 15, 2026
Image: Magnific

Coenzyme Q10 and High Blood Pressure: The Overlooked Micronutrient That Doctors Can No Longer Ignore

Unreported by the mainstream/legacy media, a major scientific review published in 2025 found that coenzyme Q10 supplementation can significantly reduce systolic blood pressure, the top number in a blood pressure test, higher readings for which are strongly linked to an increased risk of heart attacks, strokes, and premature death. Analyzing 45 randomized controlled trials involving adults with a wide range of health conditions, researchers concluded that coenzyme Q10 may offer meaningful cardiovascular benefits, particularly when taken for more than eight weeks and at doses below 200 milligrams per day. The findings add to a growing body of evidence showing that micronutrients can play an important role in preventing and controlling high blood pressure and related cardiovascular problems. At a time when millions of people worldwide are struggling with hypertension despite drug treatment, the urgent need for doctors and patients to understand the potential of nutritional approaches has become impossible to ignore.
May 8, 2026

Growing Evidence of the Benefits of Vitamin D in Multiple Sclerosis

A major new systematic review has added to the growing evidence that vitamin D may play a key role in the prevention and management of multiple sclerosis (MS). After examining data from 62 scientific studies, researchers found that people with MS generally have significantly lower vitamin D levels than healthy people, and that lower levels are linked to a greater risk of developing the disease and to more severe disability. The review also found that higher-dose vitamin D supplementation may help reduce relapses in some patients. These findings strengthen the case that doctors and patients need to be made more aware of the potential importance of vitamin D and other micronutrients in controlling MS.